Literature DB >> 7694756

Identification of both NK1 and NK2 receptors in guinea-pig airways.

K T McKee1, L Millar, I W Rodger, K M Metters.   

Abstract

1. NK1 and NK2 receptors have been characterized in guinea-pig lung membrane preparations by use of [125I-Tyr8]-substance P and [125I]-neurokinin A binding assays in conjunction with tachykinin-receptor selective agonists ([Sar9Met(O2)11]substance P for NK1 and [beta Ala8]neurokinin A (4-10) for NK2) and antagonists (CP-99,994 for NK1 and SR48968 for NK2). 2. The presence of high affinity, G-protein-coupled NK1 receptors in guinea-pig lung parenchymal membranes has been confirmed. The rank order of affinity for competing tachykinins was as predicted for an NK1 receptor: substance P = [Sar9Met(O2)11]substance P > substance P-methyl ester = physalaemin > neurokinin A = neurokinin B >> [beta Ala8]neurokinin A (4-10). The novel NK1 antagonist CP-99,994 has a Ki of 0.4 nM at this NK1 site. 3. In order to characterize [125I]-neurokinin A binding to guinea-pig lung, the number of [125I]-neurokinin A specific binding sites was increased 3-4 fold by purification of the parenchymal membranes over discontinuous sucrose gradients. The rank order of affinity determined for NK1- and NK2-receptor agonists and antagonists in competition for these sites showed that the majority (80%) of [125I]-neurokinin A specific binding was also to the NK1 receptor. 4. Under conditions where the guinea-pig lung parenchymal NK1 receptor was fully occupied by a saturating concentration of either [Sar9Met(O2)11]substance P (1 microM) or CP-99,994 (2.7 microM), residual [125I]-neurokinin A specific binding was inhibited in a concentration-dependent manner by both [beta Ala8]neurokinin A and SR48968. This result shows that the NK2 receptor is also present in these preparations. 5. Similar studies using guinea-pig tracheal membranes demonstrated that [125I]-neurokinin A specific binding was composed of a NK1-receptor component (60%), inhibited by both [Sar9Met(02)11]substance P and CP-99,994, and a significant NK2-receptor component, inhibited by both [beta Ala 8]neurokinin A andSR48968.6. In summary, these data demonstrate that guinea-pig lung parenchyma and guinea-pig trachea express both NK1 and NK2 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694756      PMCID: PMC2175923          DOI: 10.1111/j.1476-5381.1993.tb13867.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

2.  A potent and selective agonist for NK-2 tachykinin receptor.

Authors:  P Rovero; V Pestellini; R Patacchini; S Giuliani; P Santicioli; C A Maggi; A Meli; A Giachetti
Journal:  Peptides       Date:  1989 May-Jun       Impact factor: 3.750

3.  Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo.

Authors:  D J Dusser; E Umeno; P D Graf; T Djokic; D B Borson; J A Nadel
Journal:  J Appl Physiol (1985)       Date:  1988-12

4.  Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea.

Authors:  P Devillier; C Advenier; G Drapeau; J Marsac; D Regoli
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

Review 5.  Tachykinins.

Authors:  J E Maggio
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

Review 6.  New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization.

Authors:  D Regoli; G Drapeau; S Dion; R Couture
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

7.  A potent nonpeptide antagonist of the substance P (NK1) receptor.

Authors:  R M Snider; J W Constantine; J A Lowe; K P Longo; W S Lebel; H A Woody; S E Drozda; M C Desai; F J Vinick; R W Spencer
Journal:  Science       Date:  1991-01-25       Impact factor: 47.728

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

Review 9.  Pharmacological receptors for substance P and neurokinins.

Authors:  D Regoli; G Drapeau; S Dion; P D'Orléans-Juste
Journal:  Life Sci       Date:  1987-01-12       Impact factor: 5.037

10.  Highly selective agonists for substance P receptor subtypes.

Authors:  U Wormser; R Laufer; Y Hart; M Chorev; C Gilon; Z Selinger
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  2 in total

1.  Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.

Authors:  David R Sprague; Frederick T Chin; Jeih-San Liow; Masahiro Fujita; H Donald Burns; Richard Hargreaves; James B Stubbs; Victor W Pike; Robert B Innis; P David Mozley
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

2.  Heterogeneity of tachykinin receptors in the rabbit lung.

Authors:  S L Millard; J W Bloom; H I Yamamura
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.